MCHP_Logo_Vertical_4C.jpg
Microchip Technology Expands Processing Portfolio to Include Multi-Core 64-Bit Microprocessors
09 juil. 2024 05h50 HE | Microchip Technology Inc.
With its PIC64 portfolio, Microchip is expanding its computing range to meet the rising demands of today’s embedded designs and the intelligent edge.
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Compound DAO Inc.: Please contact the Portnoy Law Firm to recover your losses; February 7, 2023 deadline
22 janv. 2023 17h53 HE | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses​ LOS ANGELES, Jan. 22, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compound DAO tokens (“COMP” or...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Compound DAO Investors to Secure Counsel Before Important Deadline in Securities Class Action – COMP
16 janv. 2023 16h39 HE | The Rosen Law Firm PA
NEW YORK, Jan. 16, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Compound DAO tokens (COMP), on or after December 8, 2021,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Compound DAO Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – COMP
10 janv. 2023 12h15 HE | The Rosen Law Firm PA
NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Compound DAO tokens (COMP), on or after December 8, 2021,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Compound DAO Investors to Secure Counsel Before Important Deadline in Securities Class Action – COMP
01 janv. 2023 11h42 HE | The Rosen Law Firm PA
NEW YORK, Jan. 01, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Compound DAO tokens (COMP), on or after December 8, 2021,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Compound DAO Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – COMP
23 déc. 2022 17h15 HE | The Rosen Law Firm PA
NEW YORK, Dec. 23, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Compound DAO tokens (COMP), on or after December 8, 2021,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Compound DAO Investors to Secure Counsel Before Important Deadline in Securities Class Action – COMP
18 déc. 2022 14h25 HE | The Rosen Law Firm PA
NEW YORK, Dec. 18, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Compound DAO tokens (COMP), on or after December 8, 2021,...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Compound DAO Investors to Secure Counsel Before Important Deadline in Securities Class Action – COMP
13 déc. 2022 18h41 HE | The Rosen Law Firm PA
NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers and acquirers of Compound...
Global Tech.jpg
GLOBAL TECH INDUSTRIES GROUP, INC. ANNOUNCES ITS FILING OF A REGISTRATION STATEMENT ON FORM S-1 AND THE INTRODUCTION OF A MOBILE APP FOR ITS CRYPTO CURRENCY TRADING PLATFORM
12 juil. 2021 16h50 HE | Global Tech Industries Group, Inc.
New York, NY, July 12, 2021 (GLOBE NEWSWIRE) -- Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation, announced today that it has filed a...
EquelsHEBBioReactor.jpg
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion on Application for Orphan Designation by the European Medicines Agency for Alferon N Injection to Treat Patients With Middle East Respiratory Syndrome (MERS)
19 oct. 2015 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announces that the European subsidiary, “Hemispherx Biopharma Europe...